Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1897 (LINC01897) is a member of the class of long intergenic non-coding RNAs (lincRNAs), which are RNA transcripts longer than 200 nucleotides that do not overlap protein-coding genes[1][5]. LINC01897 does not encode a protein product and is transcribed from a genomic region that is itself noncoding, lying between coding genes[1][5]. As with many lincRNAs, the precise biological function of LINC01897 is not fully characterized; generally, lincRNAs can modulate gene expression through transcriptional regulation, chromatin remodeling, or acting as molecular scaffolds[5][3]. Many lincRNAs have specialized roles in specific cellular conditions but their functions are typically more subtle than those of protein-coding genes, often involving fine-tuning of gene expression or local effects on nearby genes[3][5]. There is currently no evidence to directly support LINC01897 as a receptor, enzyme, transporter, or other classical therapeutic target, nor is it established as a biomarker or involved in specific diseases based on available sources[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1897 (LINC01897).